• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC CARTO® 3 SYSTEM; COMPUTER, DIAGNOSTIC, PROGRAMMABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC CARTO® 3 SYSTEM; COMPUTER, DIAGNOSTIC, PROGRAMMABLE Back to Search Results
Catalog Number FG540000
Device Problem Display or Visual Feedback Problem (1184)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/22/2024
Event Type  malfunction  
Manufacturer Narrative
The hardware investigation has begun but it has not been completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster inc., or its employees that the report constitutes an admission that the product, biosense webster inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.E1.Initial reporter phone: (b)(6) 20223.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Biosense webster manufacturer's reference number (b)(4) has two reports: (1) mfr # 2029046-2024-01275 for a thermocool® smart touch® sf bi-directional navigation catheter.(2) mfr # 2029046-2024-01276 for a carto® 3 system.
 
Event Description
It was reported that a patient underwent a cardiac ablation procedure with a thermocool® smart touch® sf bi-directional navigation catheter and the patient experienced cerebrovascular accident.It was also reported there was a map shift with the carto® 3 system that was used in this case.It was reported that after switching from a trupulse generator to an ngen rf generator, remapping was performed.However, ¿confidense¿ wasn¿t adding points even though the filters were all green.Issue was quickly resolved by stopping/starting collection again.Additionally, a map/geo shift was seen after switching from the trupulse generator to an ngen rf generator (no alerts seen, and the system did not ask to ¿learn new¿); proceeded with the case by recollecting new fam and points.Similar map/geo shift seen after swapping generators; different direction of shift compared to the first case so no consistency to the movement of shift; proceeded by recollecting new fam and points.No errors were provided, the map shift confirmed during remapping.There was no cardioversion or patient movement before detecting the shift.It was also reported that following the procedure on friday morning (b)(6) 2023, the patient took some time to wake from general anesthetic.The patient also woke with left sided weakness particularly in their hand.They had a computed tomography (ct), which showed no abnormalities but because symptoms persisted they were transferred to a stroke center (royal london hospital) where a magnetic resonance imaging (mri) was performed on (b)(6) 2024.The mri showed many small emboli and a lacunar infarct.The patient¿s symptoms resolved after 2 days and they were discharged on day 3 following the procedure, however, not considered to be extended hospitalization.The physician's opinion on the adverse event is unknown.There was no evidence of char or blood/thrombus/clot during the procedure.No errors observed.No intervention provided.After the mri, the symptoms resolved and the patient was discharged with no further complaints.
 
Manufacturer Narrative
It was reported that a patient underwent a cardiac ablation procedure with a thermocool® smart touch® sf bi-directional navigation catheter and the patient experienced cerebrovascular accident.It was also reported there was a map shift with the carto® 3 system that was used in this case.It was reported that after switching from a trupulse generator to an ngen rf generator, remapping was performed.However, "confidense" wasn¿t adding points even though the filters were all green.Issue was quickly resolved by stopping/starting collection again.Additionally, a map/geo shift was seen after switching from the trupulse generator to an ngen rf generator (no alerts seen, and the system did not ask to "learn new"); proceeded with the case by recollecting new fam and points.Similar map/geo shift seen after swapping generators; different direction of shift compared to the first case so no consistency to the movement of shift; proceeded by recollecting new fam and points.No errors were provided, the map shift confirmed during remapping.There was no cardioversion or patient movement before detecting the shift.Device evaluation details: an investigation was initiated by the manufacturer to investigate the issue.It was found that the map shift occurred due to change of current distribution originated from ablator return patch introduction.User was notified.System operates as designed.The issue is related to user error.The system is ready for use.The history of customer complaints reported during the last year associated with carto 3 system #11309 was reviewed.There are no additional complaints similar to reported issue.A manufacturing record evaluation was performed for the system #11309, and no internal actions related to the reported complaint condition were identified.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference #(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARTO® 3 SYSTEM
Type of Device
COMPUTER, DIAGNOSTIC, PROGRAMMABLE
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER (ISRAEL) LTD.
4 hatnufah street
yokneam 20667 17
IS   2066717
Manufacturer Contact
kate karberg
31 technology dr
irvine, CA 92618
3035526892
MDR Report Key19127066
MDR Text Key340910999
Report Number2029046-2024-01276
Device Sequence Number1
Product Code DQK
UDI-Device Identifier10846835000870
UDI-Public10846835000870
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
K133916
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/17/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberFG540000
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/22/2024
Initial Date FDA Received04/17/2024
Supplement Dates Manufacturer Received05/04/2024
Supplement Dates FDA Received05/13/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/21/2010
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
8.5 FR VARIPULSE CATHETER; NGEN RF GENERATOR; TRUPULSE GENERATOR, WW; UNK_SMART TOUCH BIDIRECTIONAL SF
Patient SexMale
-
-